Sample Request

Global Personalized Medicine (PM) Solution Market 2021 by Company, Regions, Type and Application, Forecast to 2026

SELECT LICENSE:

Published on 04/03/2021| Code: GINR42221| Category: Information Technology| Total Pages: 112

The Personalized Medicine (PM) Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Personalized Medicine (PM) Solution size is estimated to be USD XX million in 2026 from USD XX million in 2020, with a change XX% between 2020 and 2021. The global Personalized Medicine (PM) Solution market size is expected to grow at a CAGR of XX% for the next five years.

Market segmentation

Personalized Medicine (PM) Solution market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Personalized Diagnostics

Personalized Therapies

Personalized Nutrition & Wellness

Market segment by Application, can be divided into

Oncology

Neurosciences

Immunology

Respiratory

Others

Market segment by players, this report covers

2bPrecise

OneOme

TIGAR Health- IR2Dx

Kailos Genetics

Syapse Inc

Karius

Astarte Medical

Fabric Genomics, INC.

Orion Health

2B Precise

Fabric Genomics

Pfizer

Gene 42

IBM Watson Health

Philips Healthcare

Medtronic

Nanthealth

Navican

N-of-One

PierianDx

Sunquest Information System

Tempus

Novartis

Translational Software

Biocrates Life Sciences AG

Nanostring Technologies

Thermo Fisher Scientific

Quest Diagnostics Incorporated

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Personalized Medicine (PM) Solution product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Personalized Medicine (PM) Solution, with revenue, gross margin and global market share of Personalized Medicine (PM) Solution from 2019 to 2021.

Chapter 3, the Personalized Medicine (PM) Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Personalized Medicine (PM) Solution market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Personalized Medicine (PM) Solution research findings and conclusion, appendix and data source.

1 Market Overview

1.1 Product Overview and Scope of Personalized Medicine (PM) Solution

1.2 Classification of Personalized Medicine (PM) Solution by Type

1.2.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Type in 2020

1.2.3 Personalized Diagnostics

1.2.4 Personalized Therapies

1.2.5 Personalized Nutrition & Wellness

1.3 Global Personalized Medicine (PM) Solution Market by Application

1.3.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Oncology

1.3.3 Neurosciences

1.3.4 Immunology

1.3.5 Respiratory

1.3.6 Others

1.4 Global Personalized Medicine (PM) Solution Market Size & Forecast

1.5 Global Personalized Medicine (PM) Solution Market Size and Forecast by Region

1.5.1 Global Personalized Medicine (PM) Solution Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Personalized Medicine (PM) Solution Market Size by Region, (2016-2021)

1.5.3 North America Personalized Medicine (PM) Solution Market Size and Prospect (2016-2026)

1.5.4 Europe Personalized Medicine (PM) Solution Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Personalized Medicine (PM) Solution Market Size and Prospect (2016-2026)

1.5.6 South America Personalized Medicine (PM) Solution Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Personalized Medicine (PM) Solution Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Personalized Medicine (PM) Solution Market Drivers

1.6.2 Personalized Medicine (PM) Solution Market Restraints

1.6.3 Personalized Medicine (PM) Solution Trends Analysis

2 Company Profiles

2.1 2bPrecise

2.1.1 2bPrecise Details

2.1.2 2bPrecise Major Business

2.1.3 2bPrecise Personalized Medicine (PM) Solution Product and Solutions

2.1.4 2bPrecise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 2bPrecise Recent Developments and Future Plans

2.2 OneOme

2.2.1 OneOme Details

2.2.2 OneOme Major Business

2.2.3 OneOme Personalized Medicine (PM) Solution Product and Solutions

2.2.4 OneOme Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 OneOme Recent Developments and Future Plans

2.3 TIGAR Health- IR2Dx

2.3.1 TIGAR Health- IR2Dx Details

2.3.2 TIGAR Health- IR2Dx Major Business

2.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Product and Solutions

2.3.4 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 TIGAR Health- IR2Dx Recent Developments and Future Plans

2.4 Kailos Genetics

2.4.1 Kailos Genetics Details

2.4.2 Kailos Genetics Major Business

2.4.3 Kailos Genetics Personalized Medicine (PM) Solution Product and Solutions

2.4.4 Kailos Genetics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Kailos Genetics Recent Developments and Future Plans

2.5 Syapse Inc

2.5.1 Syapse Inc Details

2.5.2 Syapse Inc Major Business

2.5.3 Syapse Inc Personalized Medicine (PM) Solution Product and Solutions

2.5.4 Syapse Inc Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Syapse Inc Recent Developments and Future Plans

2.6 Karius

2.6.1 Karius Details

2.6.2 Karius Major Business

2.6.3 Karius Personalized Medicine (PM) Solution Product and Solutions

2.6.4 Karius Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Karius Recent Developments and Future Plans

2.7 Astarte Medical

2.7.1 Astarte Medical Details

2.7.2 Astarte Medical Major Business

2.7.3 Astarte Medical Personalized Medicine (PM) Solution Product and Solutions

2.7.4 Astarte Medical Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Astarte Medical Recent Developments and Future Plans

2.8 Fabric Genomics, INC.

2.8.1 Fabric Genomics, INC. Details

2.8.2 Fabric Genomics, INC. Major Business

2.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Product and Solutions

2.8.4 Fabric Genomics, INC. Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Fabric Genomics, INC. Recent Developments and Future Plans

2.9 Orion Health

2.9.1 Orion Health Details

2.9.2 Orion Health Major Business

2.9.3 Orion Health Personalized Medicine (PM) Solution Product and Solutions

2.9.4 Orion Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Orion Health Recent Developments and Future Plans

2.10 2B Precise

2.10.1 2B Precise Details

2.10.2 2B Precise Major Business

2.10.3 2B Precise Personalized Medicine (PM) Solution Product and Solutions

2.10.4 2B Precise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 2B Precise Recent Developments and Future Plans

2.11 Fabric Genomics

2.11.1 Fabric Genomics Details

2.11.2 Fabric Genomics Major Business

2.11.3 Fabric Genomics Personalized Medicine (PM) Solution Product and Solutions

2.11.4 Fabric Genomics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Fabric Genomics Recent Developments and Future Plans

2.12 Pfizer

2.12.1 Pfizer Details

2.12.2 Pfizer Major Business

2.12.3 Pfizer Personalized Medicine (PM) Solution Product and Solutions

2.12.4 Pfizer Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Pfizer Recent Developments and Future Plans

2.13 Gene 42

2.13.1 Gene 42 Details

2.13.2 Gene 42 Major Business

2.13.3 Gene 42 Personalized Medicine (PM) Solution Product and Solutions

2.13.4 Gene 42 Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Gene 42 Recent Developments and Future Plans

2.14 IBM Watson Health

2.14.1 IBM Watson Health Details

2.14.2 IBM Watson Health Major Business

2.14.3 IBM Watson Health Personalized Medicine (PM) Solution Product and Solutions

2.14.4 IBM Watson Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 IBM Watson Health Recent Developments and Future Plans

2.15 Philips Healthcare

2.15.1 Philips Healthcare Details

2.15.2 Philips Healthcare Major Business

2.15.3 Philips Healthcare Personalized Medicine (PM) Solution Product and Solutions

2.15.4 Philips Healthcare Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Philips Healthcare Recent Developments and Future Plans

2.16 Medtronic

2.16.1 Medtronic Details

2.16.2 Medtronic Major Business

2.16.3 Medtronic Personalized Medicine (PM) Solution Product and Solutions

2.16.4 Medtronic Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Medtronic Recent Developments and Future Plans

2.17 Nanthealth

2.17.1 Nanthealth Details

2.17.2 Nanthealth Major Business

2.17.3 Nanthealth Personalized Medicine (PM) Solution Product and Solutions

2.17.4 Nanthealth Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Nanthealth Recent Developments and Future Plans

2.18 Navican

2.18.1 Navican Details

2.18.2 Navican Major Business

2.18.3 Navican Personalized Medicine (PM) Solution Product and Solutions

2.18.4 Navican Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Navican Recent Developments and Future Plans

2.19 N-of-One

2.19.1 N-of-One Details

2.19.2 N-of-One Major Business

2.19.3 N-of-One Personalized Medicine (PM) Solution Product and Solutions

2.19.4 N-of-One Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 N-of-One Recent Developments and Future Plans

2.20 PierianDx

2.20.1 PierianDx Details

2.20.2 PierianDx Major Business

2.20.3 PierianDx Personalized Medicine (PM) Solution Product and Solutions

2.20.4 PierianDx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 PierianDx Recent Developments and Future Plans

2.21 Sunquest Information System

2.21.1 Sunquest Information System Details

2.21.2 Sunquest Information System Major Business

2.21.3 Sunquest Information System Personalized Medicine (PM) Solution Product and Solutions

2.21.4 Sunquest Information System Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Sunquest Information System Recent Developments and Future Plans

2.22 Tempus

2.22.1 Tempus Details

2.22.2 Tempus Major Business

2.22.3 Tempus Personalized Medicine (PM) Solution Product and Solutions

2.22.4 Tempus Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 Tempus Recent Developments and Future Plans

2.23 Novartis

2.23.1 Novartis Details

2.23.2 Novartis Major Business

2.23.3 Novartis Personalized Medicine (PM) Solution Product and Solutions

2.23.4 Novartis Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.23.5 Novartis Recent Developments and Future Plans

2.24 Translational Software

2.24.1 Translational Software Details

2.24.2 Translational Software Major Business

2.24.3 Translational Software Personalized Medicine (PM) Solution Product and Solutions

2.24.4 Translational Software Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.24.5 Translational Software Recent Developments and Future Plans

2.25 Biocrates Life Sciences AG

2.25.1 Biocrates Life Sciences AG Details

2.25.2 Biocrates Life Sciences AG Major Business

2.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Product and Solutions

2.25.4 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.25.5 Biocrates Life Sciences AG Recent Developments and Future Plans

2.26 Nanostring Technologies

2.26.1 Nanostring Technologies Details

2.26.2 Nanostring Technologies Major Business

2.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Product and Solutions

2.26.4 Nanostring Technologies Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.26.5 Nanostring Technologies Recent Developments and Future Plans

2.27 Thermo Fisher Scientific

2.27.1 Thermo Fisher Scientific Details

2.27.2 Thermo Fisher Scientific Major Business

2.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Product and Solutions

2.27.4 Thermo Fisher Scientific Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.27.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.28 Quest Diagnostics Incorporated

2.28.1 Quest Diagnostics Incorporated Details

2.28.2 Quest Diagnostics Incorporated Major Business

2.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Product and Solutions

2.28.4 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)

2.28.5 Quest Diagnostics Incorporated Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Personalized Medicine (PM) Solution Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Personalized Medicine (PM) Solution Players Market Share

3.2.2 Top 10 Personalized Medicine (PM) Solution Players Market Share

3.2.3 Market Competition Trend

3.3 Personalized Medicine (PM) Solution Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Personalized Medicine (PM) Solution Revenue and Market Share by Type (2016-2021)

4.2 Global Personalized Medicine (PM) Solution Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Personalized Medicine (PM) Solution Revenue Market Share by Application (2016-2021)

5.2 Personalized Medicine (PM) Solution Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Personalized Medicine (PM) Solution Revenue by Type (2016-2026)

6.2 North America Personalized Medicine (PM) Solution Revenue by Application (2016-2026)

6.3 North America Personalized Medicine (PM) Solution Market Size by Country

6.3.1 North America Personalized Medicine (PM) Solution Revenue by Country (2016-2026)

6.3.2 United States Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

6.3.3 Canada Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

6.3.4 Mexico Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Personalized Medicine (PM) Solution Revenue by Type (2016-2026)

7.2 Europe Personalized Medicine (PM) Solution Revenue by Application (2016-2026)

7.3 Europe Personalized Medicine (PM) Solution Market Size by Country

7.3.1 Europe Personalized Medicine (PM) Solution Revenue by Country (2016-2026)

7.3.2 Germany Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

7.3.3 France Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

7.3.5 Russia Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

7.3.6 Italy Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Type (2016-2026)

8.2 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Application (2016-2026)

8.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region

8.3.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Region (2016-2026)

8.3.2 China Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

8.3.3 Japan Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

8.3.4 South Korea Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

8.3.5 India Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

8.3.7 Australia Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Personalized Medicine (PM) Solution Revenue by Type (2016-2026)

9.2 South America Personalized Medicine (PM) Solution Revenue by Application (2016-2026)

9.3 South America Personalized Medicine (PM) Solution Market Size by Country

9.3.1 South America Personalized Medicine (PM) Solution Revenue by Country (2016-2026)

9.3.2 Brazil Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

9.3.3 Argentina Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Type (2016-2026)

10.2 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Application (2016-2026)

10.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country

10.3.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Country (2016-2026)

10.3.2 Turkey Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

10.3.4 UAE Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp
AutoX
A.JAFFE
Aaga Marketing
AGRIC SA
Alcimed
AMSEC
Aquanova
AYTB Industrial
Bain & Company
Brooks Life Sciences
Cirona Labs
CMV Informatics
CONNEMARAORGANIC SEAWEED COMPANY
Desmet Ballestra Group
Dine4Fit, a.s.
Dream Incubator Vietnam Joint Stock Company
DSM
Eastman Chemical
Edwards Vacuum
Emerson
Getinge
Hello Flexibles
Industrie Beteiligungs Gesellschaft IBG
Inscripta, Inc.
JLL Technologies
Kari-Out
Marafie Engineering Co
Monitor Deloitte
Mossif3
mpumalanga stainless initiative
Nextteq, LLC
Pattern
Phizzle
Phronesis Partners Pte. Ltd.
PSP Specialties
Reno Refractories, Inc.
Roche Diagnostics International Ltd.
Rockfield Medical Device
RSG Media
Sealed Air
Sutton Capital Partners, Inc
Tenshi LifeCare Pvt Ltd (Velbiom Probiotics PVt Ltd)
The Crocodile Integrated Marketing Ltd
Tomorrow.io
UL
Vibrant Marketing
Wild Republic
ams OSRAM
Atelerix Life Sciences Inc
Beckman Coulter Life Sciences
BIOTECH VISION CARE PVT. LTD
Chiripal
Circle NVI
Freudenberg Filtration Technologies SE & Co. KG
FTA HSRP Solutions Pvt Ltd
Goetz Partners
Good clean love
Hasso Plattner d-school at UCT
InnoFaith Beauty Sciences
INSALA
Kukuza Consulting
MilliporeSigma
Panasonic Industry Europe
Quintus Technologies
Renesas
Roche Diagnostics International Ltd.
Timee, Inc.
YCP Solidiance
Graffer
Magnus
Pantex Ennerflo
The Japan Association of Bonded Magnetic Materials
SIS
Elian
RS Connect
3 Hunters Talent Solutions LATAM
Atelerix Life Sciences Inc
David Clark
DSGLOBAL CO.,LTD.
Hitotsubashi University
kovis-group
Saunacore
Suez Consulting
WestRock
Medeon Biodesign
Power Transmission Consulting, PTC AB
Sint Maartenskliniek
ITW Specialty Films
American Fuji Seal, Inc.
Tag-consultants.com
HAZEMAG Systems GmbH
Dabur International
lippert componentrs
Aelea Commodities Private Limited
ERRIA A/S
Chiripal Group
Capstone Partners
VETTEX SRL
Ægir Advisory Services
John Deere
ADTEC Plasma Technology
Cairneagle
Mckinsey
Panasonic Consumer Electronics Company
ACT
Mele & Co
SAZKA a.s.
THIN
Assurance Services International
Intro-act Inc
School of Health Sciences/Democritus University of Thrace
W.L.Gore
Nippon Steel Co.
AFB International
986 Labs
Bamboi
Zaptin Communications LLC
DONGIL MACHINERY
GABALabs
Salon IQ
SW Umwelttechnik Stoiser & Wolschner AG
RSM Dahman Auditors
DentalMonitoring
Emosis Diagnostics
 CDA InterCorp
Lanhe USA, Inc

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005